Agnieszka Szuster-Ciesielska

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Plasmodium Falciparum

Coronavirus Disease

Top Venues

Journal of fungi (Basel, Switzerland)

Journal of immunology research

Journal of veterinary pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Piotr Rzymski, Agnieszka Szuster-Ciesielska
Epstein-Barr virus and autoimmunity: effective preventive and therapeutic strategies are urgently needed. Reumatologia 61 (5) (2023)
Monika Sztandera-Tymoczek, Sylwia Wdowiak-Wróbel, Urszula Świderska, Marta Palusińska-Szysz, Agnieszka Szuster-Ciesielska
Potential Proallergenic Activity of Phytopathogenic Erysiphe palczewskii and Erysiphe convolvuli in in vitro Studies. Journal of inflammation research 16 (2023)
Bożena Kowalczyk, Markus Petzold, Zbigniew Kaczyński, Agnieszka Szuster-Ciesielska, Rafal Luchowski, Wiesław I Gruszecki, Beate Fuchs, Christina E Galuska, Adam Choma, Jacek Tarasiuk, Marta Palusińska-Szysz
Lipopolysaccharide of Legionella pneumophila Serogroup 1 Facilitates Interaction with Host Cells. International journal of molecular sciences 24 (19) (2023)
Monika Sztandera-Tymoczek, Agnieszka Szuster-Ciesielska
Fungal Aeroallergens-The Impact of Climate Change. Journal of fungi (Basel, Switzerland) 9 (5) (2023)
Piotr Rzymski, Agnieszka Szuster-Ciesielska
The COVID-19 Vaccination Still Matters: Omicron Variant Is a Final Wake-Up Call for the Rich to Help the Poor. Vaccines 10 (7) (2022)
Agnieszka Szuster-Ciesielska, Leszek Wawiórka, Dawid Krokowski, Nikodem Grankowski, Łukasz Jarosz, Urszula Lisiecka, Marek Tchórzewski
Immunogenic Evaluation of Ribosomal P-Protein Antigen P0, P1, and P2 and Pentameric Protein Complex P0-(P1-P2)2 of Plasmodium falciparum in a Mouse Model. Journal of immunology research 2019 (2019)
Agnieszka Szuster-Ciesielska, Renata Urban-Chmiel, Andrzej Wernicki, Laurent Mascaron, Marek Wasak, Eric Bousquet
Evaluation of the ability of colistin, amoxicillin (components of Potencil® ), and fluoroquinolones to attenuate bacterial endotoxin- and Shiga exotoxin-mediated cytotoxicity-In vitro studies. Journal of veterinary pharmacology and therapeutics 42 (1) (2018)